Long-term clinical efficacy of grass-pollen immunotherapy.

@article{Durham1999LongtermCE,
  title={Long-term clinical efficacy of grass-pollen immunotherapy.},
  author={Stephen R. Durham and Sharyn M. Walker and Eva M Varga and Mikila R Jacobson and Fiona O'Brien and Wendy Noble and Stephen Till and Qutayba A Hamid and Kayhan T. Nouri-Aria},
  journal={The New England journal of medicine},
  year={1999},
  volume={341 7},
  pages={
          468-75
        }
}
  • Stephen R. Durham, Sharyn M. Walker, +6 authors Kayhan T. Nouri-Aria
  • Published in
    The New England journal of…
    1999
  • Medicine
  • BACKGROUND Pollen immunotherapy is effective in selected patients with IgE-mediated seasonal allergic rhinitis, although it is questionable whether there is long-term benefit after the discontinuation of treatment. METHODS We conducted a randomized, double-blind, placebo-controlled trial of the discontinuation of immunotherapy for grass-pollen allergy in patients in whom three to four years of this treatment had previously been shown to be effective. During the three years of this trial… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 562 CITATIONS, ESTIMATED 45% COVERAGE

    The effect of allergen-specific immunotherapy on asthma

    VIEW 5 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Update on allergen immunotherapy for treatment of allergic diseases.

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    3-years' long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adults.

    • Rolf Dominicus
    • Medicine
    • European annals of allergy and clinical immunology
    • 2012
    VIEW 7 EXCERPTS
    CITES BACKGROUND, METHODS & RESULTS
    HIGHLY INFLUENCED

    Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.

    VIEW 3 EXCERPTS
    CITES BACKGROUND & RESULTS

    FILTER CITATIONS BY YEAR

    1995
    2020

    CITATION STATISTICS

    • 9 Highly Influenced Citations

    • Averaged 24 Citations per year from 2017 through 2019

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 24 REFERENCES

    Development of T-cell memory against inhalant allergens: risks for the future.

    • Patrick G. Holt
    • Medicine
    • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
    • 1999

    Evidence for a predominant munol

    • DS Robinson, Q Hamid, Sun Ying
    • J Exp Med
    • 1999

    IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy.

    • Cezmi A Akdis, Kelvin Blaser
    • Biology, Medicine
    • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
    • 1999

    Inhibition of T cell andpatients with severe summer hay fever uncontrolled by antiallergic antibody responses to house dust mite allergen by inhalation of thedrugs

    • VA Varney, M Gaga, +3 authors DC Wraith
    • N Engl J Med
    • 1999

    Interleukin - 10 . Annu hymenoptera venom immunotherapy

    • Golden DBK, Valentine, +3 authors R deWaalMalefyt
    • Ann Intern Med
    • 1999

    Long term clinical e ffi cacy peptides from the major cat allergen Fel d I . Proc Natl Acad Sci USA of grass pollen immunotherapy

    • SM Walker, Varga E-M
    • J Allergy Clin Immunol
    • 1998

    Nasal immunotherapy--not to be sneezed at.

    • Brigitte M. Haselden, A. B. Kay
    • Medicine
    • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
    • 1998